As of 2026-04-13, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -11.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 1,070.76 mil USD. INBX's TTM EBITDA according to its financial statements is -89.97 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 15.0x | 14.1x |
| Forward P/E multiples | 15.5x - 20.2x | 18.0x |
| Fair Price | (94.53) - (91.19) | (97.84) |
| Upside | -225.6% - -221.2% | -230.0% |
| Date | EV/EBITDA |
| 2026-04-10 | -11.90 |
| 2026-04-09 | -11.98 |
| 2026-04-08 | -10.59 |
| 2026-04-07 | -9.81 |
| 2026-04-06 | -10.03 |
| 2026-04-02 | -10.00 |
| 2026-04-01 | -10.57 |
| 2026-03-31 | -10.60 |
| 2026-03-30 | -9.41 |
| 2026-03-27 | -9.17 |
| 2026-03-26 | -10.37 |
| 2026-03-25 | -10.48 |
| 2026-03-24 | -9.94 |
| 2026-03-23 | -10.18 |
| 2026-03-20 | -9.58 |
| 2026-03-19 | -10.22 |
| 2026-03-18 | -10.84 |
| 2026-03-17 | -11.00 |
| 2026-03-16 | -10.93 |
| 2026-03-13 | -10.85 |
| 2026-03-12 | -10.94 |
| 2026-03-11 | -11.62 |
| 2026-03-10 | -11.31 |
| 2026-03-09 | -11.35 |
| 2026-03-06 | -10.92 |
| 2026-03-05 | -11.16 |
| 2026-03-04 | -11.80 |
| 2026-03-03 | -11.75 |
| 2026-03-02 | -12.26 |
| 2026-02-27 | -11.72 |
| 2026-02-26 | -12.22 |
| 2026-02-25 | -12.71 |
| 2026-02-24 | -12.58 |
| 2026-02-23 | -12.11 |
| 2026-02-20 | -12.45 |
| 2026-02-19 | -12.84 |
| 2026-02-18 | -12.92 |
| 2026-02-17 | -12.47 |
| 2026-02-13 | -11.99 |
| 2026-02-12 | -13.01 |
| 2026-02-11 | -12.99 |
| 2026-02-10 | -13.20 |
| 2026-02-09 | -13.71 |
| 2026-02-06 | -13.30 |
| 2026-02-05 | -12.91 |
| 2026-02-04 | -13.08 |
| 2026-02-03 | -13.49 |
| 2026-02-02 | -13.03 |
| 2026-01-30 | -12.06 |
| 2026-01-29 | -11.46 |